Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lymphocyte T Regulatory , Th17 and NKT in Epithelial Ovarian Tumor- Prognostic Assessment and Relationship With Clinical Marker

NCT03779399 is registered in ClinicalTrials.gov with Medical University of Lublin as lead sponsor.

NCT NCT03779399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03779399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lymphocyte T Regulatory , Th17 and NKT in Epithelial Ovarian Tumor- Prognostic Assessment and Relationship With Clinical Marker
Lead sponsor
Medical University of Lublin
Phase
Observational
Overall status
Completed
Start date
December 1, 2011
Completion date
December 31, 2016
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign ovarian tumor, borderline ovarian tumors, ovarian cancer, unexplained infertility